CLINICAL TRIALS PROFILE FOR PREGNYL

All Clinical Trials for PREGNYL

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00415766 ↗	Comparison Between Recombinant Versus Urinary hCG for Ovulation Induction in High Responders	Unknown status	Eugonia	Phase 4	2013-06-01	The purpose of this study is to compare the clinical outcomes of recombinant human chorionic gonadotrophin (rHCG) and urinary HCG (uHCG) in patients undergoing IVF cycles.
NCT00415792 ↗	Comparison Between hCG and GnRH Agonist for Ovulation Induction in Patients With High Response to IVF Drugs	Unknown status	Eugonia	Phase 4	2003-11-01	hCG and GnRH agonist can be used to induce final oocyte maturation and ovulation in IVF cycles. These two approaches will be compared in this study in terms of pregnancy rates and embryological data using patients with hyper-response to IVF drugs.
NCT00627406 ↗	Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles	Completed	Regionshospitalet Viborg, Skive	Phase 4	2009-01-01	The purpose of this study is to possibly further improve the clinical outcome and explore the incidence of OHSS in patients, who have final oocyte maturation with GnRHa (Buserelin) in GnRH antagonist IVF/ICSI cycles
NCT00809107 ↗	Frozen Embryo Transfer (FET) in Natural Cycles or in Natural Cycles Controlled by Human Chorionic Gonadotropin (hCG) Administration	Completed	Universitair Ziekenhuis Brussel	N/A	2006-10-01	The rational of the study is to assess the implantation, pregnancy and live birth rates after the transfer of frozen- thawed embryos in natural cycles with spontaneous Luteinizing Hormone (LH)/Progesterone rise or in natural cycles controlled by human chorionic gonadotropin (hCG) for final oocyte maturation and ovulation.
NCT00823004 ↗	Antagonist/Letrozole in Poor Responders	Completed	Yazd Research & Clinical Center for Infertility	Phase 1/Phase 2	2008-06-01	Failure to respond to controlled ovarian hyperstimulation (COH) is still a major concern in assisted reproduction and there is no consensus on the ovarian stimulation choice regime for poor responders. Aim: To evaluate and compare the efficacy of a microdose GnRH agonist flare (MF) and a GnRH antagonist/letrozole (A/L) protocols in poor responders undergoing in vitro fertilization (IVF). Methods: One hundred eighty poor responder patients will be randomized to an ovarian stimulation protocol with either a MF or a letrozole and high dose FSH/hMG and flexible GnRH antagonist protocol.
NCT00823121 ↗	Replacement of Fresh Embryo Transfers (ETs) by Frozen Embryo Transfers (FETs) Using Vitrification	Unknown status	Yazd Research & Clinical Center for Infertility	Phase 1/Phase 2	2008-08-01	Cryopreservation of all embryos and transferring them subsequently in assisted reproductive technology (ART) cycles to improve outcome.

Clinical Trial Conditions for PREGNYL

Condition Name

Condition Name for PREGNYL
Intervention	Trials
Infertility	12
Polycystic Ovary Syndrome	5
Invitro Fertilization	2
Female Infertility	2

Condition MeSH

Condition MeSH for PREGNYL
Intervention	Trials
Infertility	16
Polycystic Ovary Syndrome	5
Infertility, Female	3
Syndrome	3

Clinical Trial Locations for PREGNYL

Trials by Country

Trials by Country for PREGNYL
Location	Trials
Egypt	10
Belgium	5
United States	4
Greece	4
Iran, Islamic Republic of	2

Trials by US State

Trials by US State for PREGNYL
Location	Trials
Minnesota	2
Connecticut	1
Washington	1

Clinical Trial Progress for PREGNYL

Clinical Trial Phase

Clinical Trial Phase for PREGNYL
Clinical Trial Phase	Trials
Phase 4	15
Phase 3	1
Phase 2/Phase 3	5

Clinical Trial Status

Clinical Trial Status for PREGNYL
Clinical Trial Phase	Trials
Completed	18
Unknown status	11
Terminated	3

Clinical Trial Sponsors for PREGNYL

Sponsor Name

Sponsor Name for PREGNYL
Sponsor	Trials
Universitair Ziekenhuis Brussel	3
Cairo University	3
Lito Maternity Hospital	3

Sponsor Type

Sponsor Type for PREGNYL
Sponsor	Trials
Other	47
Industry	3
NIH	1